ArticleJournal of fluorescence2016
Spectroscopic Investigation and Photophysics of a D-π-A-π-D Type Styryl Pyrazine Derivative.
Article in Journal of fluorescence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Optical and Computational Studies on a Triazine Derivative of Dual Fluorescence Enhancement/Superquenching Upon Nanoparticle Interactions.Journal of fluorescence · 2026Article
- Design, Synthesis, Antimicrobial Evaluation, Molecular Docking, and Computational Studies of New 1,2,4-Triazolo[4,3-a]pyrimidin-5(1 H)-one Derivatives.Journal of fluorescence · 2025Article
- Photophysical behaviour, solvatochromism, and silver nanoparticle-induced superquenching of (E, E)-2,5-Bis(3,4,5-trimethoxystyryl) pyrazine with DFT calculations.Scientific reports · 2025Article
- Article
- Laser performance and investigation of the optimal density functional and the dependence of the basis sets for (E, E)-2,5-bis (3,4-dimethoxystyryl) pyrazine (BDP) molecule.Journal of molecular modeling · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
E,E-2,5-bis(3,4-dimethoxystyryl)pyrazine (BDSP)has been prepared by aldol condensation between 2,5-dimethypyrazine and 3,4-dimthoxybenzaldehyde and characterized by IR, 1HNMR, 13C NMR and X-ray crystallography.The electronic absorption and emission properties of BDSP were studied in different solvents. BDSP displays a strong solvatochromic effect of the emission spectrum that is reflected by large red shifts of its fluorescence emission maximum on increasing the solvent polarity, indicating a large change in dipole moment of BDSP upon excitation due to photoinduced intramolecular charge transfer (PICT). Excited state intermolecular hydrogen bonding affects the energy of emission spectrum and fluorescence quantum yield of BDSP dye. The dye solutions (1×10(-4) M) in DMSO, DMF, CH3CN and dioxane give laser emission in green region upon excitation by a 337.1 nm nitrogen pulse (λ=337 nm). The tuning range, gain coefficient (α), emission cross – section (σe) and half-life energy (E1/2) has been determined. Ground and electronic excited states geometric optimization were performed using density functional theory (DFT) and time-dependent density functional theory (TD-DFT), respectively. A DFT natural bond analysis complemented the ICT. BDSP dye displays fluorescence quenching by colloidal silver nanoparticles(AgNPs). The fluorescence data reveal that radiative and non-radiative energy transfer play a major role in the fluorescence quenching mechanism.
Identifiers
26498801What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.